Evidence mapPaperPMID 41235113Full record

ArticleFrontiers in pharmacology2025

Exposure to β-hydroxybutyrate reduces the operating set point and increases excitability in hippocampal circuitry of healthy mice.

Thais Tessari Zampieri, Guilherme Shigueto Vilar Higa, Fernando S Borges, Felipe José Costa Viana, Emily Cruvinel, Lucas Eduardo Bentivoglio, Ademar Benevolo Lugao, Henning Ulrich, Luiz Roberto Britto, Kattesh V Katti and 2 more

Abstract read
In one paragraph

Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Thais Tessari Zampieri *Laboratório de Neurofisiologia, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.
Guilherme Shigueto Vilar Higa *Laboratório de Neurofisiologia, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.
Fernando S BorgesDepartment of Physiology and Pharmacology, SUNY Downstate Health Sciences University, Brooklyn, NY, United States.
Felipe José Costa VianaLaboratório de Neurofisiologia, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.
Emily CruvinelLaboratório de Neurofisiologia, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.
Lucas Eduardo BentivoglioPhysics Department at State University of Ponta Grossa, Ponta Grossa Paraná, Brazil.
Ademar Benevolo LugaoInstituto de Pesquisas Energéticas e Nucleares IPEN-CNEN, São Paulo, Brazil.
Henning UlrichLaboratório de Neurociências, Departamento de Bioquímica, Instituto de Química (USP), São Paulo, Brazil.
Luiz Roberto BrittoLaboratório de Neurobiologia Celular, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.
Kattesh V KattiInstitute of Green Nanotechnology, Department of Radiology, School of Medicine, University of Missouri Columbia, Columbia, MO, United States.
Alton Michael ChesneDepartment of Research and Development, Tecton BG, INC, Alexandria, LA, United States.
Roberto de PasqualeLaboratório de Neurofisiologia, Departamento de Fisiologia e Biofísica, Universidade de São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ketogenic diet is a therapeutic strategy applied to reduce brain hyperexcitability in conditions such as epilepsy, Parkinson's and Alzheimer's disease, migraines, and autism. This diet reduces circulating glucose levels and increases ketone bodies, with β-hydroxybutyrate (BHB) being one of the leading promoters of the beneficial effects. BHB was previously reported as a mediator of cognitive restoration and memory formation. Herein, we investigate the effect of exogenous BHB on hippocampal neuronal excitability and synaptic plasticity mechanisms, regardless of the pathological or neurodegenerative conditions. Electrophysiological experiments were conducted to explore both passive and active neuronal properties, including action potential firing and spontaneous and evoked postsynaptic responses. Electrical stimulation along the CA3-CA1 pathway enabled the assessment of both short- and long-term synaptic plasticity, as well as the mechanisms mediated by AMPA and NMDA receptors. Experiments were conducted in hippocampal slices treated with 3-β-hydroxybutyrate glycerides (DHB) and niacin (HCAR2 agonist). Although DHB incubation did not alter passive membrane properties, it significantly increased neuronal excitability, reflected in an elevated firing rate upon depolarizing stimulation and enhanced spontaneous excitatory postsynaptic currents in CA1 pyramidal neurons, which were dependent on synaptic inputs. DHB treatment led to a reduction in long-term potentiation (LTP) in CA1 neurons, suggesting a metaplastic effect independent of NMDA receptor activation. Importantly, these DHB-induced neuronal alterations were found to be independent of HCAR2 receptor activation, supporting the involvement of distinct intracellular pathways and long-term modulatory mechanisms. Our findings indicate that DHB exerts a modulatory effect on hippocampal neural activity by enhancing excitability and concurrently promoting a compensatory reduction in LTP, suggesting a homeostatic balancing mechanism.

Indexed as

brain sliceelectrophysiologyhippocampusketonelong-term potentiation (LTP)niacinβ-hydroxybutyrate (BHB)

Identifiers

PMID41235113
PMCPMC12605301

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.